TITLE:
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression

CONDITION:
Depressive Disorder

INTERVENTION:
Ethyl-eicosapentanoic acid (ethyl-EPA)

SUMMARY:

      The purpose of this study is to examine the effectiveness of ethyl-eicosapentanoic acid
      (ethyl-EPA), an omega-3 fatty acid, in treating depression.
    

DETAILED DESCRIPTION:

      Evidence suggests that omega-3 fatty acids may help reduce symptoms of depression. This
      study will determine whether ethyl-EPA, an omega-3 fatty acid, can be used safely and
      effectively to treat major depression.

      Participants will be randomly assigned to receive either ethyl EPA-containing pills or
      placebo daily for 8 weeks. Each week, participants will be asked to complete questionnaires
      which will be used to assess the severity of their depression.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 80 Years
Criteria:

        Inclusion Criteria:

          -  Major depressive disorder

        Exclusion Criteria:

          -  Serious comorbid psychiatric disorder

          -  Unstable medical illness

          -  Prior use of any omega-3 fatty acid product
      
